Lv6
2290 积分 2021-08-12 加入
CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift?
9天前
已完结
Gastric carcinoma classification in the WHO 6th edition (2026): Updated framework and emerging entities
10天前
已完结
First-Line Retlirafusp Alfa Plus Chemotherapy for Human Epidermal Growth Factor Receptor 2–Negative Gastric or Gastroesophageal Junction Adenocarcinoma: A Randomized, Double-Blind, Phase III Study (RELIGHT)
11天前
已完结
北京市DCT项目管理体系文件要点专家共识
2个月前
已完结
Pan-RAS inhibitor daraxonrasib shows promise in pancreatic cancer
2个月前
已完结
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model‐Based Assessments
2个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
3个月前
已完结
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors
3个月前
已完结
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
3个月前
已完结
Savolitinib in MET-amplified gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial
3个月前
已完结
皖公网安备34019202002308
